Erysipeloid: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(71 intermediate revisions by 5 users not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{PTD}}, {{Faizan}}
{{CMG}}; {{AE}} {{PTD}}, {{Faizan}}


'''''Synonyms and Keywords''''': Erysipelotrichosis, Rose fish-handlers disease, Rosenbach's disease, Rosenbach's Erysipeloid or Erysipeloid of Rosenbach.
'''''Synonyms and Keywords''''': Erysipelotrichosis, Rose fish-handlers disease, Rosenbach's disease, Rosenbach's Erysipeloid or Erysipeloid of Rosenbach
{{Infobox Disease |
{{Infobox Disease |
   Name          = Erysipeloid |
   Name          = Erysipeloid |
Line 21: Line 21:
==Overview==
==Overview==


Erysipeloid is an occupational infection of the skin caused by traumatic penetration of [[Erysipelothrix rhusiopathiae]] (formerly E. insidiosa). The disease is characterized clinically by an erythematous [[edema]], with well-defined and raised borders, usually localized to the back of one hand and/or fingers. Vesicular, bullous, and erosive [[lesions]] may also be present. The lesions may be asymptomatic or accompanied by mild [[pruritus]], pain and [[fever]]. In addition to cutaneous infection, E. rhusiopathiae can cause [[endocarditis]], which may be acute or subacute. Endocarditis is rare and has a male predilection. It usually occurs in previously damaged valves, predominantly the [[aortic valve]]. [[Endocarditis]] does not occur in patients with valvular prostheses and is not associated with intravenous [[drug misuse]]. Diagnosis of localized erysipeloid is based on the patient's history (occupation, previous traumatic contact with infected animals or their meat) and clinical picture (typically skin [[lesions]], lack of severe systemic features, slight laboratory abnormalities and rapid remission after treatment with [[penicillin]] or [[cephalosporin]]).
Erysipeloid is an occupational infection resulting from introduction of [[Erysipelothrix rhusiopathiae]] (formerly E. insidiosa) into a traumatized patch of skin. Clinically, the disease is observed as erythematous [[edema]], with well-defined and raised borders. Lesions are mostly localized to the back of the hand. Vesicular, bullous, and erosive [[lesions]] may also be present. The lesions are usually asymptomatic and occasionally associated with pain, [[fever]], and mild [[pruritus]]. In addition to cutaneous infection, E. rhusiopathiae may be complicated by acute or subacute [[endocarditis]]. Endocarditis is rare and has a male predilection. It usually occurs in previously damaged valves, predominantly the [[aortic valve]]. [[Endocarditis]] does not occur in patients with valvular prostheses and is not associated with intravenous [[drug misuse]]. Eysipeloid is a clinical diagnosis. Affected patients usually present with a history of occupational exposure to unprocessed fish<ref name=Lehane_2000>{{cite journal |author=Lehane L, Rawlin G |title=Topically acquired bacterial zoonoses from fish: a review |journal=Med J Aust |volume=173 |issue=5 |pages=256–9 |year=2000 |pmid=11130351}}</ref> or meat with characteristic cutaneous lesions.<ref name=Brooke_1999>{{cite journal |doi=10.1099/00222615-48-9-789 |author=Brooke C, Riley T |title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen |journal=J Med Microbiol |volume=48 |issue=9 |pages=789–99 |year=1999 |pmid=10482289}}</ref><ref>{{cite web|url=http://www.dft.gov.uk/mca/mcga-shs_capt_guide_chap8.pdf|page=190|title=THE SHIP CAPTAIN’S MEDICAL GUIDE}}</ref> It typically  gains entry through abrasions in the hand. [[Bacteremia]] and [[endocarditis]] are uncommon but serious complications.<ref name=Brouqui_2001>{{cite journal |author=Brouqui P, Raoult D |title=Endocarditis due to rare and fastidious bacteria |journal=Clin Microbiol Rev |volume=14 |issue=1 |pages=177–207 |year=2001 |pmid=11148009 |doi=10.1128/CMR.14.1.177-207.2001 |pmc=88969}}</ref><ref name=Nassar_2005>{{cite journal |author=Nassar I, de la Llana R, Garrido P, Martinez-Sanz R |title=Mitro-aortic infective endocarditis produced by ''Erysipelothrix rhusiopathiae'': case report and review of the literature |journal=J Heart Valve Dis |volume=14 |issue=3 |pages=320–4 |year=2005 |pmid=15974525}}</ref> Erysipeloid is frequently misidentified due to the rarity of reported cases.<ref name=Brooke_1999 />
 
In humans, ''[[Erysipelothrix rhusiopathiae]]'' infections most commonly present in a mild [[cutaneous]] form known as '''erysipeloid'''<ref name=Brooke_1999>{{cite journal |doi=10.1099/00222615-48-9-789 |author=Brooke C, Riley T |title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen |journal=J Med Microbiol |volume=48 |issue=9 |pages=789–99 |year=1999 |pmid=10482289}}</ref> or '''fish poisoning'''.<ref>{{cite web|url=http://www.dft.gov.uk/mca/mcga-shs_capt_guide_chap8.pdf|page=190|title=THE SHIP CAPTAIN’S MEDICAL GUIDE}}</ref>  ''E. rhusiopathiae'' can cause an indolent [[cellulitis]], most commonly in individuals who handle fish and raw meat.<ref name=Lehane_2000>{{cite journal |author=Lehane L, Rawlin G |title=Topically acquired bacterial zoonoses from fish: a review |journal=Med J Aust |volume=173 |issue=5 |pages=256–9 |year=2000 |pmid=11130351}}</ref> It typically  gains entry through abrasions in the hand. [[Bacteremia]] and [[endocarditis]] are uncommon but serious sequelae.<ref name=Brouqui_2001>{{cite journal |author=Brouqui P, Raoult D |title=Endocarditis due to rare and fastidious bacteria |journal=Clin Microbiol Rev |volume=14 |issue=1 |pages=177–207 |year=2001 |pmid=11148009 |doi=10.1128/CMR.14.1.177-207.2001 |pmc=88969}}</ref><ref name=Nassar_2005>{{cite journal |author=Nassar I, de la Llana R, Garrido P, Martinez-Sanz R |title=Mitro-aortic infective endocarditis produced by ''Erysipelothrix rhusiopathiae'': case report and review of the literature |journal=J Heart Valve Dis |volume=14 |issue=3 |pages=320–4 |year=2005 |pmid=15974525}}</ref> Due to the rarity of reported human cases, ''E. rhusiopathiae'' infections are frequently misidentified at presentation.<ref name=Brooke_1999 />


==Historical Perspective==
==Historical Perspective==
*In 1884, Friedrich Julius Rosenbach (also called Anton Julius Friedrich Rosenbach), a German physician and microbiologist, was the first to accurately describe the association between [[Erysipelothrix rhusiopathiae]] and development of erysipeloid.
*In 1884, Friedrich Julius Rosenbach (also called Anton Julius Friedrich Rosenbach), a German physician and microbiologist, was the first to accurately describe the association between [[Erysipelothrix rhusiopathiae]] and the development of erysipeloid.
*[[Erysipelothrix rhusiopathiae]] was first isolated from mice in 1880 by Robert Koch. <ref name=erysipeloid>{{cite book |last= Mandell|first= Gerald |date= 1985 |title=principles and practice of infectious diseases |location=New York |publisher=John Wiley & sons |page=1185 |isbn=0-471-87643-7}}</ref><ref name="pmid10482289">{{cite journal| author=Brooke CJ, Riley TV| title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. | journal=J Med Microbiol | year= 1999 | volume= 48 | issue= 9 | pages= 789-99 | pmid=10482289 | doi=10.1099/00222615-48-9-789 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10482289  }} </ref>
*[[Erysipelothrix rhusiopathiae]] was first isolated from mice in 1880 by Robert Koch. <ref name=erysipeloid>{{cite book |last= Mandell|first= Gerald |date= 1985 |title=principles and practice of infectious diseases |location=New York |publisher=John Wiley & sons |page=1185 |isbn=0-471-87643-7}}</ref><ref name="pmid10482289">{{cite journal| author=Brooke CJ, Riley TV| title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. | journal=J Med Microbiol | year= 1999 | volume= 48 | issue= 9 | pages= 789-99 | pmid=10482289 | doi=10.1099/00222615-48-9-789 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10482289  }} </ref>


Line 34: Line 32:
===Localized cutaneous erysipeloid===
===Localized cutaneous erysipeloid===
*Usually a mild, localized infection
*Usually a mild, localized infection
*Patients present with local swelling and redness of the skin
*Patients present with localized swelling and redness of the skin
*Popularly referred to as "erysipeloid of Rosenbach"
*Commonly referred to as "erysipeloid of Rosenbach"


===Diffuse cutaneous erysipeloid===
===Diffuse cutaneous erysipeloid===
Line 46: Line 44:


===Pathogenesis===
===Pathogenesis===
 
Erysipeloid results from an infection with [[Erysipelothrix rhusiopathiae]] after an area of skin containing an abrasion comes into contact with contaminated fish, poultry, or raw meat.<ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref>
Development of erysipeloid  is the result of an infection with [[Erysipelothrix rhusiopathiae]] after an area of skin containing an abrasion comes into contact with contaminated fish, poultry, or raw meat.<ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref>
The organism is known for its high environmental resistance.<ref name="pmid10482289">{{cite journal| author=Brooke CJ, Riley TV| title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. | journal=J Med Microbiol | year= 1999 | volume= 48 | issue= 9 | pages= 789-99 | pmid=10482289 | doi=10.1099/00222615-48-9-789 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10482289  }} </ref> Various virulence factors have been implicated in the pathogenicity of erysipeloid. Following infection in the skin, the organism produces certain enzymes that help it dissect its way through the tissues. Significant among them are [[hyaluronidase]] and [[neuraminidase]].<ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref> [[Neuraminidase]] has been shown to play vital role in the attachment of [[Erysipelothrix rhusiopathiae]]. This subsequently aids in the invasion of host cells. The role of [[hyaluronidase]] in the disease process is not well understood. The presence of a heat labile capsule has been reported as being important in virulence.<ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref>. At the same time, the patient's immune response is activated to fight against the organism. Failure of the immune surveillance leads to systemic dissemination of the bacteria to the [[heart]], [[brain]], [[kidney]], [[vascular system]], [[joints]], [[central nervous system]], and [[lungs]]. The heart is the most commonly affected systemic organ.
[[Erysipelothrix rhusiopathiae]], which is highly resistant to environmental factors,<ref name="pmid10482289">{{cite journal| author=Brooke CJ, Riley TV| title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. | journal=J Med Microbiol | year= 1999 | volume= 48 | issue= 9 | pages= 789-99 | pmid=10482289 | doi=10.1099/00222615-48-9-789 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10482289  }} </ref> enters the skin through scratches or pricks. Various virulence factors have been implicated in the pathogenicity of erysipeloid. Following infection in the skin, the organism produces certain enzymes that help it dissect its way through the tissues. Significant among them are [[hyaluronidase]] and [[neuraminidase]].<ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref> [[Neuraminidase]] has been shown to play a significant role in the attachment of [[Erysipelothrix rhusiopathiae]] and subsequent invasion of host cells. The role of [[hyaluronidase]] in the disease process is less clear. The presence of a heat labile capsule has been reported as important in virulence.<ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref> It has been discovered that only pathogenic strains of [[Erysipelothrix rhusiopathiae]] are capable of producing the [[neuraminidase]] enzyme. In addition, two adhesive surface proteins&mdash;RspA and RspB&mdash;also help the microorganism bind to [[collagen]] (types I and IV) and [[polystyrene]] surfaces. Meanwhile, the host's immune system is activated to start fighting against this foreign bacterium. The organism may escape immune surveillance and may spread in the body via the [[vascular system]] to the [[joints]], [[heart]], [[brain]], [[kidney]], [[central nervous system]], and [[lungs]]. Besides the skin, the most commonly affected organ is the heart.


===Associated conditions===
===Associated conditions===
The following conditions are associated with erysipeloid:
The following conditions are associated with erysipeloid:<ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref><ref name="pmid23140319">{{cite journal| author=Foster JD, Hartmann FA, Moriello KA| title=A case of apparent canine erysipeloid associated with Erysipelothrix rhusiopathiae bacteraemia. | journal=Vet Dermatol | year= 2012 | volume= 23 | issue= 6 | pages= 528-e108 | pmid=23140319 | doi=10.1111/j.1365-3164.2012.01115.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23140319  }} </ref><ref name="pmid10699048">{{cite journal| author=Dunbar SA, Clarridge JE| title=Potential errors in recognition of Erysipelothrix rhusiopathiae. | journal=J Clin Microbiol | year= 2000 | volume= 38 | issue= 3 | pages= 1302-4 | pmid=10699048 | doi= | pmc=88613 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10699048  }} </ref><ref name="pmid22957967">{{cite journal| author=Boyd AS, Ritchie C, Fenton JS| title=Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child. | journal=Pediatr Dermatol | year= 2014 | volume= 31 | issue= 2 | pages= 232-5 | pmid=22957967 | doi=10.1111/j.1525-1470.2012.01835.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22957967  }} </ref><ref name="pmid25118689">{{cite journal| author=Mazellier S, Hubiche T, Weinbreck N, Gutnecht J, Del Giudice P| title=Erysipeloid Hodgkin lymphoma. | journal=Eur J Dermatol | year= 2014 | volume= 24 | issue= 4 | pages= 513-4 | pmid=25118689 | doi=10.1684/ejd.2014.2392 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25118689  }} </ref><ref name="pmid25860686">{{cite journal| author=Chaabane H, Amouri M, Meziou TJ, Dammak A, Bouassida S, Boudawara T et al.| title=[Sweet's syndrome: a rare cause of erysipeloid dermatitis]. | journal=Tunis Med | year= 2014 | volume= 92 | issue= 10 | pages= 649-50 | pmid=25860686 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25860686  }} </ref>
*[[Endocarditis]]<ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref><ref name="pmid23140319">{{cite journal| author=Foster JD, Hartmann FA, Moriello KA| title=A case of apparent canine erysipeloid associated with Erysipelothrix rhusiopathiae bacteraemia. | journal=Vet Dermatol | year= 2012 | volume= 23 | issue= 6 | pages= 528-e108 | pmid=23140319 | doi=10.1111/j.1365-3164.2012.01115.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23140319  }} </ref><ref name="pmid10699048">{{cite journal| author=Dunbar SA, Clarridge JE| title=Potential errors in recognition of Erysipelothrix rhusiopathiae. | journal=J Clin Microbiol | year= 2000 | volume= 38 | issue= 3 | pages= 1302-4 | pmid=10699048 | doi= | pmc=88613 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10699048  }} </ref><ref name="pmid22957967">{{cite journal| author=Boyd AS, Ritchie C, Fenton JS| title=Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child. | journal=Pediatr Dermatol | year= 2014 | volume= 31 | issue= 2 | pages= 232-5 | pmid=22957967 | doi=10.1111/j.1525-1470.2012.01835.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22957967  }} </ref>
*[[Endocarditis]]
*[[Hodgkins lymphoma]]<ref name="pmid25118689">{{cite journal| author=Mazellier S, Hubiche T, Weinbreck N, Gutnecht J, Del Giudice P| title=Erysipeloid Hodgkin lymphoma. | journal=Eur J Dermatol | year= 2014 | volume= 24 | issue= 4 | pages= 513-4 | pmid=25118689 | doi=10.1684/ejd.2014.2392 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25118689  }} </ref>
*[[Hodgkins lymphoma]]
*Use of [[gemcitabine]]<ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref>
*Use of [[gemcitabine]]
*[[Sweet's syndrome]]<ref name="pmid25860686">{{cite journal| author=Chaabane H, Amouri M, Meziou TJ, Dammak A, Bouassida S, Boudawara T et al.| title=[Sweet's syndrome: a rare cause of erysipeloid dermatitis]. | journal=Tunis Med | year= 2014 | volume= 92 | issue= 10 | pages= 649-50 | pmid=25860686 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25860686  }} </ref>
*[[Sweet's syndrome]]
*[[Renal failure]]<ref name="pmid10699048">{{cite journal| author=Dunbar SA, Clarridge JE| title=Potential errors in recognition of Erysipelothrix rhusiopathiae. | journal=J Clin Microbiol | year= 2000 | volume= 38 | issue= 3 | pages= 1302-4 | pmid=10699048 | doi= | pmc=88613 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10699048  }} </ref>
*[[Renal failure]]
*[[Septic arthritis]]<ref name="pmid10699048">{{cite journal| author=Dunbar SA, Clarridge JE| title=Potential errors in recognition of Erysipelothrix rhusiopathiae. | journal=J Clin Microbiol | year= 2000 | volume= 38 | issue= 3 | pages= 1302-4 | pmid=10699048 | doi= | pmc=88613 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10699048  }} </ref>
*[[Septic arthritis]]
*[[Polyarthralgia]]<ref name="pmid10699048">{{cite journal| author=Dunbar SA, Clarridge JE| title=Potential errors in recognition of Erysipelothrix rhusiopathiae. | journal=J Clin Microbiol | year= 2000 | volume= 38 | issue= 3 | pages= 1302-4 | pmid=10699048 | doi= | pmc=88613 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10699048  }} </ref>
*[[Polyarthralgia]]


==Causes==
==Causes==




Erysipeloid is caused by an infection with [[Erysipelothrix rhusiopathiae]], a [[Gram-positive]], catalase-negative, rod-shaped, non-spore-forming, non-acid-fast, non-motile [[bacterium]]. Infection with [[Erysipelothrix rhusiopathiae]] commonly results from contact between skin containing [[abrasions]] or [[lesions]] and contaminated fish, poultry, or raw meat. <ref name="pmid10482289">{{cite journal| author=Brooke CJ, Riley TV| title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. | journal=J Med Microbiol | year= 1999 | volume= 48 | issue= 9 | pages= 789-99 | pmid=10482289 | doi=10.1099/00222615-48-9-789 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10482289  }} </ref><ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref><ref name="pmid10699048">{{cite journal| author=Dunbar SA, Clarridge JE| title=Potential errors in recognition of Erysipelothrix rhusiopathiae. | journal=J Clin Microbiol | year= 2000 | volume= 38 | issue= 3 | pages= 1302-4 | pmid=10699048 | doi= | pmc=88613 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10699048  }} </ref><ref name="pmid22957967">{{cite journal| author=Boyd AS, Ritchie C, Fenton JS| title=Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child. | journal=Pediatr Dermatol | year= 2014 | volume= 31 | issue= 2 | pages= 232-5 | pmid=22957967 | doi=10.1111/j.1525-1470.2012.01835.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22957967  }} </ref>
Erysipeloid is caused by an infection with [[Erysipelothrix rhusiopathiae]], a [[Gram-positive]] rod bacteria. Infection with [[Erysipelothrix rhusiopathiae]] commonly results from contact between skin containing [[abrasions]] or [[lesions]] and contaminated fish, poultry, or raw meat. <ref name="pmid10482289">{{cite journal| author=Brooke CJ, Riley TV| title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. | journal=J Med Microbiol | year= 1999 | volume= 48 | issue= 9 | pages= 789-99 | pmid=10482289 | doi=10.1099/00222615-48-9-789 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10482289  }} </ref><ref name="pmid19733019">{{cite journal| author=Wang Q, Chang BJ, Riley TV| title=Erysipelothrix rhusiopathiae. | journal=Vet Microbiol | year= 2010 | volume= 140 | issue= 3-4 | pages= 405-17 | pmid=19733019 | doi=10.1016/j.vetmic.2009.08.012 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19733019  }} </ref><ref name="pmid10699048">{{cite journal| author=Dunbar SA, Clarridge JE| title=Potential errors in recognition of Erysipelothrix rhusiopathiae. | journal=J Clin Microbiol | year= 2000 | volume= 38 | issue= 3 | pages= 1302-4 | pmid=10699048 | doi= | pmc=88613 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10699048  }} </ref><ref name="pmid22957967">{{cite journal| author=Boyd AS, Ritchie C, Fenton JS| title=Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child. | journal=Pediatr Dermatol | year= 2014 | volume= 31 | issue= 2 | pages= 232-5 | pmid=22957967 | doi=10.1111/j.1525-1470.2012.01835.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22957967  }} </ref>


==Differentiating {{PAGENAME}} from Other Diseases==
==Differentiating {{PAGENAME}} from Other Diseases==
Erysipeloid must be differentiated from other conditions as follows:
Erysipeloid must be differentiated from the following conditions:
*[[Abscess]]
*[[Abscess]]
*[[Cellulitis]]
*[[Cellulitis]]
Line 83: Line 80:


===Sex===
===Sex===
Both sexes may be equally affected; however, erysipeloid seems to affect more males than females because of occupational exposure.
Males are more commonly affected with erysipeloid than females because of the relative frequency of occupational exposure.


===Age===
===Age===
Line 90: Line 87:
==Risk Factors==
==Risk Factors==
Erysipeloid is most common among individuals who have direct contact with infected animals.  
Erysipeloid is most common among individuals who have direct contact with infected animals.  
The following are among those at highest risk for contracting the condition:<ref name=erysipeloid>{{cite book |last= Mandell|first= Gerald |date= 1985 |title=principles and practice of infectious diseases |location=New York |publisher=John Wiley & sons |page=1185 |isbn=0-471-87643-7}}</ref>
People in the following occupations are at the highest risk for contracting the condition:<ref name=erysipeloid>{{cite book |last= Mandell|first= Gerald |date= 1985 |title=principles and practice of infectious diseases |location=New York |publisher=John Wiley & sons |page=1185 |isbn=0-471-87643-7}}</ref>
*Fishermen  
*Fishermen  
*Farmers
*Farmers
Line 101: Line 98:


==Screening==
==Screening==
There is no screening modality for erysipeloid.<ref name=erysipeloid>{{cite book |last= Mandell|first= Gerald |date= 1985 |title=principles and practice of infectious diseases |location=New York |publisher=John Wiley & sons |page=1185 |isbn=0-471-87643-7}}</ref>
There is no established screening modality for erysipeloid.<ref name=erysipeloid>{{cite book |last= Mandell|first= Gerald |date= 1985 |title=principles and practice of infectious diseases |location=New York |publisher=John Wiley & sons |page=1185 |isbn=0-471-87643-7}}</ref>


==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==
Cutaneous forms of the disease usually resolve spontaneously.<ref name="pmid22957967">{{cite journal| author=Boyd AS, Ritchie C, Fenton JS| title=Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child. | journal=Pediatr Dermatol | year= 2014 | volume= 31 | issue= 2 | pages= 232-5 | pmid=22957967 | doi=10.1111/j.1525-1470.2012.01835.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22957967  }} </ref> The prognosis is excellent with appropriate antibiotics. Inadequate treatment can lead to complications such as [[endocarditis]] or [[arthritis]].
[[Antibiotic-resistant]] strains will complicate therapy. Repeated infection may result in the development of [[allergies]]. Reduced immunity may complicate the infection. Individuals with the severe, systemic form of erysipeloid may suffer irreversible neurological damage. [[Endocarditis]] may result in long-term [[valvular heart disease]]. [[Septic arthritis]] may result in long-term joint disease.


The local and cutaneous forms of the disease are usually self-limiting and may resolve spontaneously.<ref name="pmid22957967">{{cite journal| author=Boyd AS, Ritchie C, Fenton JS| title=Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child. | journal=Pediatr Dermatol | year= 2014 | volume= 31 | issue= 2 | pages= 232-5 | pmid=22957967 | doi=10.1111/j.1525-1470.2012.01835.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22957967  }} </ref> In individuals receiving appropriate antibiotic treatment, the prognosis for complete recovery is excellent. In those who are not treated adequately, endocarditis or arthritis may develop, but these conditions are not usually severe and can be effectively treated. Needle aspiration of an infected joint, possibly repeated on multiple occasions, will, in conjunction with antibiotic therapy, lead to resolution of the arthritis.
==Diagnosis==


Antibiotic-resistant strains will complicate therapy. Repeated infection may result in the development of allergic sensitivities. Reduced immunity may complicate the infection. Individuals with the severe systemic form may have irreversible neurological damage. Endocarditis may result in long-term valvular heart disease. Septic arthritis may result in long-term joint disease.
===History and Symptoms===


==Diagnosis==
Patients with erysipeloid usually present with a history of occupational exposure to unprocessed fish or meat.


===History and Symptoms===
Symptoms may include:<ref name="pmid19663854">{{cite journal| author=Veraldi S, Girgenti V, Dassoni F, Gianotti R| title=Erysipeloid: a review. | journal=Clin Exp Dermatol | year= 2009 | volume= 34 | issue= 8 | pages= 859-62 | pmid=19663854 | doi=10.1111/j.1365-2230.2009.03444.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19663854  }} </ref>
*skin irritation
*localized burning sensation
*[[itching]]
*[[pain]]


A person with erysipeloid infection usually presents with a history of an occupation requiring handling of unprocessed meat or fish. Symptoms may include skin irritations either of the localized or the diffuse form. Individuals may report burning, itching, or pain. If systemic infection is present, symptoms may include fever, chills, fatigue, or malaise.<ref name="pmid19486064">{{cite journal| author=Veraldi S, Girgenti V, Gianotti R| title=Erysipeloid. | journal=Clin Exp Dermatol | year= 2009 | volume= 34 | issue= 8 | pages= e605-7 | pmid=19486064 | doi=10.1111/j.1365-2230.2009.03292.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19486064  }} </ref>
Patients with [[systemic infections]] may present with:<ref name="pmid19486064">{{cite journal| author=Veraldi S, Girgenti V, Gianotti R| title=Erysipeloid. | journal=Clin Exp Dermatol | year= 2009 | volume= 34 | issue= 8 | pages= e605-7 | pmid=19486064 | doi=10.1111/j.1365-2230.2009.03292.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19486064  }} </ref>
*[[fever]]
*[[chills]]
*[[fatigue]]
*[[malaise]]


===Physical Examination===
===Physical Examination===
On physical examination the affected area usually shows bright red-to-purple, nonvesiculated, maculopapular plaques with a smooth, shiny surface, typically found on the webs of the fingers, hands, or forearms; the lesions are clearly defined, raised, and indurated. The rash or lesions may be warm and/or tender. Fever is occasionally present. Individuals with joint involvement may have swelling of some joints. Individuals with [[endocarditis]] may have a heart [[murmur]] noted on examination.<ref name="pmid19486064">{{cite journal| author=Veraldi S, Girgenti V, Gianotti R| title=Erysipeloid. | journal=Clin Exp Dermatol | year= 2009 | volume= 34 | issue= 8 | pages= e605-7 | pmid=19486064 | doi=10.1111/j.1365-2230.2009.03292.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19486064  }} </ref>
 
Physical examination of patients with erysipeloid is usually remarkable for lesions with the following features:<ref name=erysipeloid>{{cite book |last= Mandell|first= Gerald |date= 1985 |title=principles and practice of infectious diseases |location=New York |publisher=John Wiley & sons |page=1185 |isbn=0-471-87643-7}}</ref><ref name="pmid21251895">{{cite journal| author=Mnejja M, Hammami B, Chakroun A, Achour I, Charfeddine I, Chakroun A et al.| title=Unusual form of cutaneous leishmaniasis: erysipeloid form. | journal=Eur Ann Otorhinolaryngol Head Neck Dis | year= 2011 | volume= 128 | issue= 2 | pages= 95-7 | pmid=21251895 | doi=10.1016/j.anorl.2010.09.008 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21251895  }} </ref><ref name="pmid19663854">{{cite journal| author=Veraldi S, Girgenti V, Dassoni F, Gianotti R| title=Erysipeloid: a review. | journal=Clin Exp Dermatol | year= 2009 | volume= 34 | issue= 8 | pages= 859-62 | pmid=19663854 | doi=10.1111/j.1365-2230.2009.03444.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19663854  }} </ref><ref name="pmid19486064">{{cite journal| author=Veraldi S, Girgenti V, Gianotti R| title=Erysipeloid. | journal=Clin Exp Dermatol | year= 2009 | volume= 34 | issue= 8 | pages= e605-7 | pmid=19486064 | doi=10.1111/j.1365-2230.2009.03292.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19486064  }} </ref><ref name="pmid26693283">{{cite journal| author=Tolis K, Spyridonos S, Tsiplakou S, Fandridis E| title=Tenosynovitis of a digit due to Erysipelothrix rhusiopathiae: case report and review of the literature. | journal=New Microbes New Infect | year= 2015 | volume= 8 | issue=  | pages= 128-30 | pmid=26693283 | doi=10.1016/j.nmni.2015.10.007 | pmc=4659811 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26693283  }} </ref>
#purplish-red rash with associated burning and itching
#crusted formation
#erythematous [[edema]] or infiltrative plaque with raised borders
#localized [[tenderness]]
#joint lesions may manifest as [[tenosynovitis]]
#individuals with [[endocarditis]] may have a heart [[murmur]] noted on examination


===Laboratory Findings===
===Laboratory Findings===
Laboratory investigations are usually not need to make diagnosis of erysipeloid since the diagnosis is mostly clinical. However, cuture of a  
Laboratory investigations are usually not needed to diagnose erysipeloid since the diagnosis is mostly clinical.<ref name="pmid19663854">{{cite journal| author=Veraldi S, Girgenti V, Dassoni F, Gianotti R| title=Erysipeloid: a review. | journal=Clin Exp Dermatol | year= 2009 | volume= 34 | issue= 8 | pages= 859-62 | pmid=19663854 | doi=10.1111/j.1365-2230.2009.03444.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19663854  }} </ref>
specimen from drainage from the infected area may yield the diagnosis. Sometimes, a full-thickness biopsy culture is needed to make the diagnosis. Blood culture is necessary for the diagnosis of erysipeloid endocarditis.  


===Imaging Findings===
===Imaging Findings===
 
CT scans may be helpful in the diagnosis of erysipeloid endocarditis. A CT scan may show vegetations, paravalvular abscesses, and/or [[pseudoaneurysm]]s.
CT scan may be helpful in the diagnosis of erysipeloid endocarditis. CT scan may show vegetations, paravalvular abscesses, and [[pseudoaneurysm]]s.


==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===
The treatment of choice is a single dose of [[Penicillin#Benzathine|benzathine benzylpenicillin]] given by [[intramuscular injection]], or a five-day to one-week course of either [[penicillin#Phenoxymethylpenicillin/penicillin V|oral penicillin]] or intramuscular [[procaine benzylpenicillin]].<ref name="pmid22957967">{{cite journal| author=Boyd AS, Ritchie C, Fenton JS| title=Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child. | journal=Pediatr Dermatol | year= 2014 | volume= 31 | issue= 2 | pages= 232-5 | pmid=22957967 | doi=10.1111/j.1525-1470.2012.01835.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22957967  }} </ref><ref name="pmid10482289">{{cite journal| author=Brooke CJ, Riley TV| title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. | journal=J Med Microbiol | year= 1999 | volume= 48 | issue= 9 | pages= 789-99 | pmid=10482289 | doi=10.1099/00222615-48-9-789 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10482289  }} </ref><ref name=POC-IT>{{cite web |url=http://prod.hopkins-abxguide.org/pathogens/bacteria/aerobic_gram_positive_bacillus/erysipelothrix_rhusiopathiae.html |title=''Erysipelothrix rhusiopathiae''  |author=Vinetz J |date=October 4, 2007 |work=Point-of-Care Information Technology ABX Guide |publisher=[[Johns Hopkins University]]}} Retrieved on October 28, 2008. Freely available with registration.</ref> [[Erythromycin]] or [[doxycycline]] may be given instead to people who are allergic to penicillin. ''E. rhusiopathiae'' is intrinsically [[antibiotic resistance|resistant]] to [[vancomycin]].<ref name=POC-IT/>
The treatment of choice is intramuscular [[Penicillin#Benzathine|benzathine benzylpenicillin]], [[penicillin#Phenoxymethylpenicillin/penicillin V|oral penicillin]], or intramuscular procaine benzylpenicillin.<ref name="pmid22957967">{{cite journal| author=Boyd AS, Ritchie C, Fenton JS| title=Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child. | journal=Pediatr Dermatol | year= 2014 | volume= 31 | issue= 2 | pages= 232-5 | pmid=22957967 | doi=10.1111/j.1525-1470.2012.01835.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22957967  }} </ref><ref name="pmid10482289">{{cite journal| author=Brooke CJ, Riley TV| title=Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. | journal=J Med Microbiol | year= 1999 | volume= 48 | issue= 9 | pages= 789-99 | pmid=10482289 | doi=10.1099/00222615-48-9-789 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10482289  }} </ref><ref name=POC-IT>{{cite web |url=http://prod.hopkins-abxguide.org/pathogens/bacteria/aerobic_gram_positive_bacillus/erysipelothrix_rhusiopathiae.html |title=''Erysipelothrix rhusiopathiae''  |author=Vinetz J |date=October 4, 2007 |work=Point-of-Care Information Technology ABX Guide |publisher=[[Johns Hopkins University]]}} Retrieved on October 28, 2008. Freely available with registration.</ref>  
 
Patients who are allergic to penicillin may be treated with [[erythromycin]] or [[doxycycline]].<ref name=POC-IT/>
 
===Surgery===
Surgery is usually not necessary. However, in rare cases with massive valvular destruction complicating endocarditis, surgical valvular replacement may be needed.<ref name="pmid2697071">{{cite journal| author=Rocha MP, Fontoura PR, Azevedo SN, Fontoura AM| title=Erysipelothrix endocarditis with previous cutaneous lesion: report of a case and review of the literature. | journal=Rev Inst Med Trop Sao Paulo | year= 1989 | volume= 31 | issue= 4 | pages= 286-9 | pmid=2697071 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2697071  }} </ref>
 
==Prevention==
 
===Primary prevention===
Effective measures for the primary prevention of erysipeloid include <ref name=erysipeloid>{{cite book |last= Mandell|first= Gerald |date= 1985 |title=principles and practice of infectious diseases |location=New York |publisher=John Wiley & sons |page=1185 |isbn=0-471-87643-7}}</ref>:
*Individuals whose work include meat handling, fishing, and agricultural jobs should wear protective gloves when possible to avoid infection with contaminated food.
*Individuals with erysipeloid should be restricted from handling meat or fish products until the infection is cured.
 
===Secondary Prevention===
There are no secondary preventive measures available for erysipeloid.


===Antimicrobial Regimen===
===Antimicrobial Regimen===
Line 166: Line 165:
::* Alternative regimen (4): [[Daptomycin]] 6 mg/kg IV q24h for 4-6 weeks
::* Alternative regimen (4): [[Daptomycin]] 6 mg/kg IV q24h for 4-6 weeks
::* Note: Recommended duration of therapy for endocarditis is 4 to 6 weeks, although shorter courses consisting of 2 weeks of intravenous therapy followed by 2 to 4 weeks of oral therapy have been successful.
::* Note: Recommended duration of therapy for endocarditis is 4 to 6 weeks, although shorter courses consisting of 2 weeks of intravenous therapy followed by 2 to 4 weeks of oral therapy have been successful.
===Surgery===
Surgery is usually not necessary for the management of erysipeloid. However, in rare cases with massive valvular destruction complicating endocarditis, surgical valvular replacement may be needed.<ref name="pmid2697071">{{cite journal| author=Rocha MP, Fontoura PR, Azevedo SN, Fontoura AM| title=Erysipelothrix endocarditis with previous cutaneous lesion: report of a case and review of the literature. | journal=Rev Inst Med Trop Sao Paulo | year= 1989 | volume= 31 | issue= 4 | pages= 286-9 | pmid=2697071 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2697071  }} </ref>
==Prevention==
===Primary prevention===
Effective measures for the primary prevention of erysipeloid include:<ref name=erysipeloid>{{cite book |last= Mandell|first= Gerald |date= 1985 |title=principles and practice of infectious diseases |location=New York |publisher=John Wiley & sons |page=1185 |isbn=0-471-87643-7}}</ref>
*Individuals whose work involves handling raw meat, fishing, and/or agricultural jobs should wear protective gloves when possible to avoid infection with contaminated food.
*Restriction of food-handling in people diagnosed with erysipeloid.
===Secondary Prevention===
There are no established methods of secondary prevention for erysipeloid.


==See also==
==See also==
Line 175: Line 187:
{{Gram-positive bacterial diseases}}
{{Gram-positive bacterial diseases}}
{{Cutaneous infections}}
{{Cutaneous infections}}
[[Category:Dermatology]]


{{WS}}
{{WS}}
{{WH}}
{{WH}}
[[Category:Dermatology]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]

Latest revision as of 21:39, 29 July 2020

WikiDoc Resources for Erysipeloid

Articles

Most recent articles on Erysipeloid

Most cited articles on Erysipeloid

Review articles on Erysipeloid

Articles on Erysipeloid in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Erysipeloid

Images of Erysipeloid

Photos of Erysipeloid

Podcasts & MP3s on Erysipeloid

Videos on Erysipeloid

Evidence Based Medicine

Cochrane Collaboration on Erysipeloid

Bandolier on Erysipeloid

TRIP on Erysipeloid

Clinical Trials

Ongoing Trials on Erysipeloid at Clinical Trials.gov

Trial results on Erysipeloid

Clinical Trials on Erysipeloid at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Erysipeloid

NICE Guidance on Erysipeloid

NHS PRODIGY Guidance

FDA on Erysipeloid

CDC on Erysipeloid

Books

Books on Erysipeloid

News

Erysipeloid in the news

Be alerted to news on Erysipeloid

News trends on Erysipeloid

Commentary

Blogs on Erysipeloid

Definitions

Definitions of Erysipeloid

Patient Resources / Community

Patient resources on Erysipeloid

Discussion groups on Erysipeloid

Patient Handouts on Erysipeloid

Directions to Hospitals Treating Erysipeloid

Risk calculators and risk factors for Erysipeloid

Healthcare Provider Resources

Symptoms of Erysipeloid

Causes & Risk Factors for Erysipeloid

Diagnostic studies for Erysipeloid

Treatment of Erysipeloid

Continuing Medical Education (CME)

CME Programs on Erysipeloid

International

Erysipeloid en Espanol

Erysipeloid en Francais

Business

Erysipeloid in the Marketplace

Patents on Erysipeloid

Experimental / Informatics

List of terms related to Erysipeloid

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2], Faizan Sheraz, M.D. [3]

Synonyms and Keywords: Erysipelotrichosis, Rose fish-handlers disease, Rosenbach's disease, Rosenbach's Erysipeloid or Erysipeloid of Rosenbach

Erysipeloid
Cellular and colonial morphology of Erysipelothrix rhusiopathiae
ICD-10 A26
ICD-9 027.1
DiseasesDB 4432
MedlinePlus 000632
eMedicine derm/602 
MeSH D004887

Overview

Erysipeloid is an occupational infection resulting from introduction of Erysipelothrix rhusiopathiae (formerly E. insidiosa) into a traumatized patch of skin. Clinically, the disease is observed as erythematous edema, with well-defined and raised borders. Lesions are mostly localized to the back of the hand. Vesicular, bullous, and erosive lesions may also be present. The lesions are usually asymptomatic and occasionally associated with pain, fever, and mild pruritus. In addition to cutaneous infection, E. rhusiopathiae may be complicated by acute or subacute endocarditis. Endocarditis is rare and has a male predilection. It usually occurs in previously damaged valves, predominantly the aortic valve. Endocarditis does not occur in patients with valvular prostheses and is not associated with intravenous drug misuse. Eysipeloid is a clinical diagnosis. Affected patients usually present with a history of occupational exposure to unprocessed fish[1] or meat with characteristic cutaneous lesions.[2][3] It typically gains entry through abrasions in the hand. Bacteremia and endocarditis are uncommon but serious complications.[4][5] Erysipeloid is frequently misidentified due to the rarity of reported cases.[2]

Historical Perspective

  • In 1884, Friedrich Julius Rosenbach (also called Anton Julius Friedrich Rosenbach), a German physician and microbiologist, was the first to accurately describe the association between Erysipelothrix rhusiopathiae and the development of erysipeloid.
  • Erysipelothrix rhusiopathiae was first isolated from mice in 1880 by Robert Koch. [6][7]

Classification

Erysipeloid may be classified into the following categories according to the severity of the condition:[7]

Localized cutaneous erysipeloid

  • Usually a mild, localized infection
  • Patients present with localized swelling and redness of the skin
  • Commonly referred to as "erysipeloid of Rosenbach"

Diffuse cutaneous erysipeloid

  • Patients may present with fever

Generalized or systemic erysipeloid

Pathophysiology

Pathogenesis

Erysipeloid results from an infection with Erysipelothrix rhusiopathiae after an area of skin containing an abrasion comes into contact with contaminated fish, poultry, or raw meat.[8] The organism is known for its high environmental resistance.[7] Various virulence factors have been implicated in the pathogenicity of erysipeloid. Following infection in the skin, the organism produces certain enzymes that help it dissect its way through the tissues. Significant among them are hyaluronidase and neuraminidase.[8] Neuraminidase has been shown to play vital role in the attachment of Erysipelothrix rhusiopathiae. This subsequently aids in the invasion of host cells. The role of hyaluronidase in the disease process is not well understood. The presence of a heat labile capsule has been reported as being important in virulence.[8]. At the same time, the patient's immune response is activated to fight against the organism. Failure of the immune surveillance leads to systemic dissemination of the bacteria to the heart, brain, kidney, vascular system, joints, central nervous system, and lungs. The heart is the most commonly affected systemic organ.

Associated conditions

The following conditions are associated with erysipeloid:[8][9][10][11][12][13]

Causes

Erysipeloid is caused by an infection with Erysipelothrix rhusiopathiae, a Gram-positive rod bacteria. Infection with Erysipelothrix rhusiopathiae commonly results from contact between skin containing abrasions or lesions and contaminated fish, poultry, or raw meat. [7][8][10][11]

Differentiating Erysipeloid from Other Diseases

Erysipeloid must be differentiated from the following conditions:

Epidemiology and Demographics

Infection with E. rhusiopathiae occurs worldwide in a variety of animals, including sheep, rabbits, turkeys, birds, cattle, rats, and fish.[6]

Race

No racial predilection is recognized for erysipeloid.

Sex

Males are more commonly affected with erysipeloid than females because of the relative frequency of occupational exposure.

Age

Erysipeloid can affect any age group.

Risk Factors

Erysipeloid is most common among individuals who have direct contact with infected animals. People in the following occupations are at the highest risk for contracting the condition:[6]

  • Fishermen
  • Farmers
  • Slaughterhouse workers
  • Butchers
  • Meat handlers
  • Agricultural workers

Erysipeloid is observed most frequently during the summer and early fall.[7]

Screening

There is no established screening modality for erysipeloid.[6]

Natural History, Complications, and Prognosis

Cutaneous forms of the disease usually resolve spontaneously.[11] The prognosis is excellent with appropriate antibiotics. Inadequate treatment can lead to complications such as endocarditis or arthritis. Antibiotic-resistant strains will complicate therapy. Repeated infection may result in the development of allergies. Reduced immunity may complicate the infection. Individuals with the severe, systemic form of erysipeloid may suffer irreversible neurological damage. Endocarditis may result in long-term valvular heart disease. Septic arthritis may result in long-term joint disease.

Diagnosis

History and Symptoms

Patients with erysipeloid usually present with a history of occupational exposure to unprocessed fish or meat.

Symptoms may include:[14]

  • skin irritation
  • localized burning sensation
  • itching
  • pain

Patients with systemic infections may present with:[15]

Physical Examination

Physical examination of patients with erysipeloid is usually remarkable for lesions with the following features:[6][16][14][15][17]

  1. purplish-red rash with associated burning and itching
  2. crusted formation
  3. erythematous edema or infiltrative plaque with raised borders
  4. localized tenderness
  5. joint lesions may manifest as tenosynovitis
  6. individuals with endocarditis may have a heart murmur noted on examination

Laboratory Findings

Laboratory investigations are usually not needed to diagnose erysipeloid since the diagnosis is mostly clinical.[14]

Imaging Findings

CT scans may be helpful in the diagnosis of erysipeloid endocarditis. A CT scan may show vegetations, paravalvular abscesses, and/or pseudoaneurysms.

Treatment

Medical Therapy

The treatment of choice is intramuscular benzathine benzylpenicillin, oral penicillin, or intramuscular procaine benzylpenicillin.[11][7][18] Patients who are allergic to penicillin may be treated with erythromycin or doxycycline.[18]

Antimicrobial Regimen

  • Preferred regimen (1): Penicillin 500 mg qid for 7–10 days
  • Preferred regimen (2): Amoxicillin 500 mg tid for 7–10 days
  • Erysipelothrix rhusiopathiae [19]
  • 1. Erysipeloid of Rosenbach (localized cutaneous infection)
  • 2. Diffuse cutaneous infection
  • Preferred regimen: See localized infection
  • 3. Bacteremia or endocarditis
  • Preferred regimen: Penicillin G benzathine 2-4 MU IV q4h for 4-6 weeks
  • Alternative regimen (1): Ceftriaxone 2 g IV q24h for 4-6 weeks
  • Alternative regimen (2): Imipenem 500 mg IV q6h for 4-6 weeks
  • Alternative regimen (3): Ciprofloxacin 400 mg IV q12h for 4-6 weeks
  • Alternative regimen (4): Daptomycin 6 mg/kg IV q24h for 4-6 weeks
  • Note: Recommended duration of therapy for endocarditis is 4 to 6 weeks, although shorter courses consisting of 2 weeks of intravenous therapy followed by 2 to 4 weeks of oral therapy have been successful.

Surgery

Surgery is usually not necessary for the management of erysipeloid. However, in rare cases with massive valvular destruction complicating endocarditis, surgical valvular replacement may be needed.[20]

Prevention

Primary prevention

Effective measures for the primary prevention of erysipeloid include:[6]

  • Individuals whose work involves handling raw meat, fishing, and/or agricultural jobs should wear protective gloves when possible to avoid infection with contaminated food.
  • Restriction of food-handling in people diagnosed with erysipeloid.

Secondary Prevention

There are no established methods of secondary prevention for erysipeloid.

See also

References

  1. Lehane L, Rawlin G (2000). "Topically acquired bacterial zoonoses from fish: a review". Med J Aust. 173 (5): 256–9. PMID 11130351.
  2. 2.0 2.1 Brooke C, Riley T (1999). "Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen". J Med Microbiol. 48 (9): 789–99. doi:10.1099/00222615-48-9-789. PMID 10482289.
  3. "THE SHIP CAPTAIN'S MEDICAL GUIDE" (PDF). p. 190.
  4. Brouqui P, Raoult D (2001). "Endocarditis due to rare and fastidious bacteria". Clin Microbiol Rev. 14 (1): 177–207. doi:10.1128/CMR.14.1.177-207.2001. PMC 88969. PMID 11148009.
  5. Nassar I, de la Llana R, Garrido P, Martinez-Sanz R (2005). "Mitro-aortic infective endocarditis produced by Erysipelothrix rhusiopathiae: case report and review of the literature". J Heart Valve Dis. 14 (3): 320–4. PMID 15974525.
  6. 6.0 6.1 6.2 6.3 6.4 6.5 Mandell, Gerald (1985). principles and practice of infectious diseases. New York: John Wiley & sons. p. 1185. ISBN 0-471-87643-7.
  7. 7.0 7.1 7.2 7.3 7.4 7.5 Brooke CJ, Riley TV (1999). "Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen". J Med Microbiol. 48 (9): 789–99. doi:10.1099/00222615-48-9-789. PMID 10482289.
  8. 8.0 8.1 8.2 8.3 8.4 Wang Q, Chang BJ, Riley TV (2010). "Erysipelothrix rhusiopathiae". Vet Microbiol. 140 (3–4): 405–17. doi:10.1016/j.vetmic.2009.08.012. PMID 19733019.
  9. Foster JD, Hartmann FA, Moriello KA (2012). "A case of apparent canine erysipeloid associated with Erysipelothrix rhusiopathiae bacteraemia". Vet Dermatol. 23 (6): 528-e108. doi:10.1111/j.1365-3164.2012.01115.x. PMID 23140319.
  10. 10.0 10.1 Dunbar SA, Clarridge JE (2000). "Potential errors in recognition of Erysipelothrix rhusiopathiae". J Clin Microbiol. 38 (3): 1302–4. PMC 88613. PMID 10699048.
  11. 11.0 11.1 11.2 11.3 Boyd AS, Ritchie C, Fenton JS (2014). "Cutaneous Erysipelothrix rhusiopathiae (erysipeloid) infection in an immunocompromised child". Pediatr Dermatol. 31 (2): 232–5. doi:10.1111/j.1525-1470.2012.01835.x. PMID 22957967.
  12. Mazellier S, Hubiche T, Weinbreck N, Gutnecht J, Del Giudice P (2014). "Erysipeloid Hodgkin lymphoma". Eur J Dermatol. 24 (4): 513–4. doi:10.1684/ejd.2014.2392. PMID 25118689.
  13. Chaabane H, Amouri M, Meziou TJ, Dammak A, Bouassida S, Boudawara T; et al. (2014). "[Sweet's syndrome: a rare cause of erysipeloid dermatitis]". Tunis Med. 92 (10): 649–50. PMID 25860686.
  14. 14.0 14.1 14.2 Veraldi S, Girgenti V, Dassoni F, Gianotti R (2009). "Erysipeloid: a review". Clin Exp Dermatol. 34 (8): 859–62. doi:10.1111/j.1365-2230.2009.03444.x. PMID 19663854.
  15. 15.0 15.1 Veraldi S, Girgenti V, Gianotti R (2009). "Erysipeloid". Clin Exp Dermatol. 34 (8): e605–7. doi:10.1111/j.1365-2230.2009.03292.x. PMID 19486064.
  16. Mnejja M, Hammami B, Chakroun A, Achour I, Charfeddine I, Chakroun A; et al. (2011). "Unusual form of cutaneous leishmaniasis: erysipeloid form". Eur Ann Otorhinolaryngol Head Neck Dis. 128 (2): 95–7. doi:10.1016/j.anorl.2010.09.008. PMID 21251895.
  17. Tolis K, Spyridonos S, Tsiplakou S, Fandridis E (2015). "Tenosynovitis of a digit due to Erysipelothrix rhusiopathiae: case report and review of the literature". New Microbes New Infect. 8: 128–30. doi:10.1016/j.nmni.2015.10.007. PMC 4659811. PMID 26693283.
  18. 18.0 18.1 Vinetz J (October 4, 2007). "Erysipelothrix rhusiopathiae". Point-of-Care Information Technology ABX Guide. Johns Hopkins University. Retrieved on October 28, 2008. Freely available with registration.
  19. Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.
  20. Rocha MP, Fontoura PR, Azevedo SN, Fontoura AM (1989). "Erysipelothrix endocarditis with previous cutaneous lesion: report of a case and review of the literature". Rev Inst Med Trop Sao Paulo. 31 (4): 286–9. PMID 2697071.

Template:Cutaneous infections

Template:WS Template:WH